Jacqueline L Deen
Overview
Explore the profile of Jacqueline L Deen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
53
Citations
1898
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Affordable house designs to improve health in rural Africa: a field study from northeastern Tanzania
von Seidlein L, Ikonomidis K, Mshamu S, Nkya T, Mukaka M, Pell C, et al.
Lancet Planet Health
. 2018 Jun;
1(5):e188-e199.
PMID: 29851640
Background: The population of sub-Saharan Africa is currently estimated to be 1245 million and is expected to quadruple by the end of the century, necessitating the building of millions of...
2.
von Seidlein L, Deen J
PLoS Med
. 2018 Feb;
15(2):e1002510.
PMID: 29485984
In a Perspective, Lorenz von Seidlein and Jacqueline L. Deen discuss the implications of Andrew Azman and colleagues' accompanying study for management of cholera outbreaks.
3.
von Seidlein L, Sack D, Azman A, Ivers L, Lopez A, Deen J
Lancet Gastroenterol Hepatol
. 2017 Oct;
2(11):777.
PMID: 29017710
No abstract available.
4.
Ali M, You Y, Kanungo S, Manna B, Deen J, Lopez A, et al.
Vaccine
. 2015 Sep;
33(48):6878-83.
PMID: 26364121
Background: Case-control studies have not been examined for their utility in assessing population-level vaccine protection in individually randomized trials. Methods: We used the data of a randomized, placebo-controlled trial of...
5.
Anh D, Lopez A, Tran H, Van Cuong N, Thiem V, Ali M, et al.
PLoS Med
. 2014 Sep;
11(9):e1001712.
PMID: 25180511
No abstract available.
6.
Bhattacharya S, Sur D, Ali M, Kanungo S, You Y, Manna B, et al.
Lancet Infect Dis
. 2013 Oct;
13(12):1050-6.
PMID: 24140390
Background: Efficacy and safety of a two-dose regimen of bivalent killed whole-cell oral cholera vaccine (Shantha Biotechnics, Hyderabad, India) to 3 years is established, but long-term efficacy is not. We...
7.
You Y, Ali M, Kanungo S, Sah B, Manna B, Puri M, et al.
PLoS One
. 2013 Aug;
8(8):e71173.
PMID: 23936491
Background: Despite advancement of our knowledge, cholera remains a public health concern. During March-April 2010, a large cholera outbreak afflicted the eastern part of Kolkata, India. The quantification of importance...
8.
Ali M, Sur D, You Y, Kanungo S, Sah B, Manna B, et al.
Clin Infect Dis
. 2013 Jan;
56(8):1123-31.
PMID: 23362293
Background: We evaluated the herd protection conferred by an oral cholera vaccine using 2 approaches: cluster design and geographic information system (GIS) design. Methods: Residents living in 3933 dwellings (clusters)...
9.
Hashim R, Khatib A, Enwere G, Park J, Reyburn R, Ali M, et al.
PLoS Negl Trop Dis
. 2012 Aug;
6(7):e1743.
PMID: 22848772
Introduction: Mass vaccinations are a main strategy in the deployment of oral cholera vaccines. Campaigns avoid giving vaccine to pregnant women because of the absence of safety data of the...
10.
von Seidlein L, Deen J
Emerg Infect Dis
. 2012 Jun;
18(7):1211-4.
PMID: 22709425
No abstract available.